English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Regulatory

+ Regulatory
Vimbai Chikomo | May 3, 2016

Premiums and deductibles set to increase for majority of states as ACA subsidies expire

+ Regulatory
Vimbai Chikomo | May 2, 2016

Rep. Jim Jordan: Americans about to feel 'full effects' of ACA in November

+ Community
Amanda Rupp | May 2, 2016

ADA grants four Professional Interest Group Awards

+ Technology/Innovation
Amanda Rupp | May 1, 2016

NORD publishes 20 rare disease patient groups in FDA cooperation

+ Regulatory
Amanda Rupp | May 1, 2016

Inflectra awarded FDA approval

+ Regulatory
Amanda Rupp | May 1, 2016

AAFP announces MACRA recommendations

+ Technology/Innovation
Amanda Rupp | May 1, 2016

Bococizumab SPIRE-2 study completes enrollment process

+ Technology/Innovation
Amanda Rupp | May 1, 2016

Autism Speaks approves ban of aversive shock devices

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 457
  • 458
  • 459
  • 460
  • 461
  • 462
  • 463
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily